申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP1314719A1
公开(公告)日:2003-05-28
A pharmaceutical composition, which comprises a benzoic acid derivative of formula (I)
wherein R1 is COOH, COOR6 etc.; A, B is carbocyclic ring or heterocyclic ring; R2 is alkyl, alkenyl, alkynyl etc.; R4 is alkyl, cycloalkyl etc.; R5 is carbocyclic ring or heterocyclic ring;
or non-toxic salts thereof.
The compound of the formula (I) can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show the antagonizing activity, and useful for the prevention and/or treatment of disease, for example, pain, allergy, Alzheimer' s disease, cancer.
一种药物组合物,它包括式 (I) 的苯甲酸衍生物
其中 R1 是 COOH、COOR6 等;A、B 是碳环或杂环;R2 是烷基、烯基、炔基等;R4 是烷基、环烷基等;R5 是碳环或杂环;
或其无毒盐。
式(I)化合物可与前列腺素 E2 受体,特别是 EP3 受体和/或 EP4 受体结合,显示出拮抗活性,可用于预防和/或治疗疾病,例如疼痛、过敏、老年痴呆症、癌症。